Okur, Volkan
Chen, Zefu
Vossaert, Liesbeth
Peacock, Sandra
Rosenfeld, Jill http://orcid.org/0000-0001-5664-7987
Zhao, Lina
Du, Haowei
Calamaro, Emily
Gerard, Amanda
Zhao, Sen
Kelsay, Jill
Lahr, Ashley
Mighton, Chloe
Porter, Hillary M. http://orcid.org/0000-0002-9554-8006
Siemon, Amy
Silver, Josh
Svihovec, Shayna http://orcid.org/0000-0002-9359-1916
Fong, Chin-To
Grant, Christina L. http://orcid.org/0000-0002-0627-4614
Lerner-Ellis, Jordan
Manickam, Kandamurugu
Madan-Khetarpal, Suneeta
McCandless, Shawn E.
Morel, Chantal F.
Schaefer, G. Bradley
Berry-Kravis, Elizabeth M.
Gates, Ryan
Gomez-Ospina, Natalia
Qiu, Guixing
Zhang, Terry Jianguo
Wu, Zhihong
Meng, Linyan
Liu, Pengfei
Scott, Daryl A. http://orcid.org/0000-0003-1460-5169
Lupski, James R. http://orcid.org/0000-0001-9907-9246
Eng, Christine M.
Wu, Nan http://orcid.org/0000-0002-9429-2889
Yuan, Bo http://orcid.org/0000-0001-7278-5116
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (UM1 HG008900, UM1HG006542)
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (FRN: 135790)
National Natural Science Foundation of China (81772301 and 81972132, 81930068 and 81772299, 81822030 and 82072391)
Chinese Academy of Medical Sciences (2020-I2M-C&T-B-030, 2019PT320025)
Natural Science Foundation of Beijing Municipality (7191007, JQ20032)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
Article History
Received: 20 April 2021
Accepted: 28 October 2021
First Online: 7 December 2021
Competing interests
: Baylor College of Medicine and Miraca Holdings Inc. have formed a joint venture with shared ownership and governance of BG, formerly the Baylor Miraca Genetics Laboratories (BMGL), which performs chromosomal microarray analysis and clinical exome sequencing. S.P., L.M., P.L., and C.M.E. are employees of BCM and derive support through a professional services agreement with BG. J.R.L. serves on the Scientific Advisory Board of the Regeneron Genetics Center and has stock ownership in 23andMe. The other authors declare no competing interests.